- Home
- PCH vs SLNO Comparison
PCH vs SLNO Comparison
Compare PCH & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCH
- SLNO
- Stock Information
- Founded
- PCH 1903
- SLNO 1999
- Country
- PCH United States
- SLNO United States
- Employees
- PCH N/A
- SLNO N/A
- Industry
- PCH Real Estate Investment Trusts
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PCH Real Estate
- SLNO Health Care
- Exchange
- PCH Nasdaq
- SLNO Nasdaq
- Market Cap
- PCH 3.2B
- SLNO 3.8B
- IPO Year
- PCH N/A
- SLNO 2014
- Fundamental
- Price
- PCH $42.54
- SLNO $68.94
- Analyst Decision
- PCH Strong Buy
- SLNO Strong Buy
- Analyst Count
- PCH 7
- SLNO 10
- Target Price
- PCH $49.86
- SLNO $112.50
- AVG Volume (30 Days)
- PCH 611.3K
- SLNO 1.6M
- Earning Date
- PCH 07-28-2025
- SLNO 08-06-2025
- Dividend Yield
- PCH 4.23%
- SLNO N/A
- EPS Growth
- PCH 15.06
- SLNO N/A
- EPS
- PCH 0.53
- SLNO N/A
- Revenue
- PCH $1,056,523,000.00
- SLNO $32,656,999.00
- Revenue This Year
- PCH $1.69
- SLNO N/A
- Revenue Next Year
- PCH $5.46
- SLNO $209.31
- P/E Ratio
- PCH $80.37
- SLNO N/A
- Revenue Growth
- PCH N/A
- SLNO N/A
- 52 Week Low
- PCH $36.82
- SLNO $41.50
- 52 Week High
- PCH $48.12
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- PCH 52.65
- SLNO 32.07
- Support Level
- PCH $42.58
- SLNO $66.72
- Resistance Level
- PCH $43.58
- SLNO $87.17
- Average True Range (ATR)
- PCH 0.94
- SLNO 4.00
- MACD
- PCH -0.07
- SLNO -1.90
- Stochastic Oscillator
- PCH 49.32
- SLNO 21.79
About PCH PotlatchDeltic Corporation
PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.